[Various aspects of the oral treatment of fat diabetes. Value of a new biguanide derivative: glucinan].
D003920:Diabetes Mellitus / Q000188:drug therapy*; D004338:Drug Combinations; D006016:Glycolates / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008687:Metformin / Q000009:adverse effects / Q000627:therapeutic use*
D004338:Drug Combinations; D006016:Glycolates; D008687:Metformin; C015237:Glucinan
Aspects du traitement oral du diabéte gras. Apport d'un nouveau dérivé biguanidique: le glucinan.